255 related articles for article (PubMed ID: 27258253)
21. Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy.
Lee SY; Kang HG; Yoo SS; Kang YR; Choi YY; Lee WK; Choi JE; Jeon HS; Shin KM; Oh IJ; Kim KS; Lee J; Cha SI; Kim CH; Kim YC; Park JY
Lung Cancer; 2013 Nov; 82(2):330-9. PubMed ID: 23973201
[TBL] [Abstract][Full Text] [Related]
22. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K
Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504
[TBL] [Abstract][Full Text] [Related]
23. LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p.
Nie W; Ge HJ; Yang XQ; Sun X; Huang H; Tao X; Chen WS; Li B
Cancer Lett; 2016 Feb; 371(1):99-106. PubMed ID: 26655272
[TBL] [Abstract][Full Text] [Related]
24. Multiple end-point analysis reveals cisplatin damage tolerance to be a chemoresistance mechanism in a NSCLC model: implications for predictive testing.
Almeida GM; Duarte TL; Farmer PB; Steward WP; Jones GD
Int J Cancer; 2008 Apr; 122(8):1810-9. PubMed ID: 18074354
[TBL] [Abstract][Full Text] [Related]
25. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.
Kalikaki A; Kanaki M; Vassalou H; Souglakos J; Voutsina A; Georgoulias V; Mavroudis D
Clin Lung Cancer; 2009 Mar; 10(2):118-23. PubMed ID: 19362955
[TBL] [Abstract][Full Text] [Related]
26. DNA methylation and nonsmall cell lung cancer.
Lu F; Zhang HT
Anat Rec (Hoboken); 2011 Nov; 294(11):1787-95. PubMed ID: 21956844
[TBL] [Abstract][Full Text] [Related]
27. Concurrent paclitaxel-based chemo-radiotherapy for post-surgical microscopic residual tumor at the bronchial margin (R1 resection) in non-small-cell lung cancer.
Zhou M; Li T; Liu Y; Sun C; Li N; Xu Y; Zhu J; Ding Z; Wang Y; Huang M; Peng F; Wang J; Ren L; Lu Y; Gong Y
BMC Cancer; 2015 Feb; 15():36. PubMed ID: 25655307
[TBL] [Abstract][Full Text] [Related]
28. [The challenge of local control in unresectable locally advanced non-small cell lung cancer].
Barthelemy N; Lennerts E; Meyns M; Duysinx B; Paulus A; Compère C; Bosquée L; Jérusalem G; Coucke P
Rev Med Liege; 2014; 69 Suppl 1():75-80. PubMed ID: 24822310
[TBL] [Abstract][Full Text] [Related]
29. Surgical Results of Non-small Cell Lung Cancer in Nepal.
Thakur B; Yonghui D; Devkota M; Poudel B; Baral P
JNMA J Nepal Med Assoc; 2014; 52(196):992-6. PubMed ID: 26982898
[TBL] [Abstract][Full Text] [Related]
30. hOGG1 Ser326Cys polymorphism and G:C-to-T:A mutations: no evidence for a role in tobacco-related non small cell lung cancer.
Hu YC; Ahrendt SA
Int J Cancer; 2005 Apr; 114(3):387-93. PubMed ID: 15551330
[TBL] [Abstract][Full Text] [Related]
31. The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients.
Deng J; Liang Y; Liu C; He S; Wang S
Biomed Pharmacother; 2015 Oct; 75():8-11. PubMed ID: 26463625
[TBL] [Abstract][Full Text] [Related]
32. DNA crosslinks, DNA damage and repair in peripheral blood lymphocytes of non-small cell lung cancer patients treated with platinum derivatives.
Fikrova P; Stetina R; Hrnciarik M; Hrnciarikova D; Hronek M; Zadak Z
Oncol Rep; 2014 Jan; 31(1):391-6. PubMed ID: 24154806
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
34. Bevacizumab radiosensitizes non-small cell lung cancer xenografts by inhibiting DNA double-strand break repair in endothelial cells.
Gao H; Xue J; Zhou L; Lan J; He J; Na F; Yang L; Deng L; Lu Y
Cancer Lett; 2015 Aug; 365(1):79-88. PubMed ID: 25982206
[TBL] [Abstract][Full Text] [Related]
35. [Review of chemoradiotherapy followed by surgical resection in locally advanced non-small-cell lung cancer].
Futamura Y; Sawa T; Hasegawa T; Horiba A; Ishiguro T; Yoshida T; Kinoshita T; Marui T; Murakami E; Azuma K; Murakawa S; Iida T
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2390-2. PubMed ID: 23268087
[TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patients.
Pircher A; Gamerith G; Amann A; Reinold S; Popper H; Gächter A; Pall G; Wöll E; Jamnig H; Gastl G; Wolf AM; Hilbe W; Wolf D
Lung Cancer; 2014 Jul; 85(1):81-7. PubMed ID: 24780112
[TBL] [Abstract][Full Text] [Related]
37. MiR-95 induces proliferation and chemo- or radioresistance through directly targeting sorting nexin1 (SNX1) in non-small cell lung cancer.
Chen X; Chen S; Hang W; Huang H; Ma H
Biomed Pharmacother; 2014 Jun; 68(5):589-95. PubMed ID: 24835695
[TBL] [Abstract][Full Text] [Related]
38. Disease-free survival of patients after surgical resection of non-small cell lung carcinoma and correlation with excision repair cross-complementation group 1 expression and genotype.
Tseden-Ish M; Choi YD; Cho HJ; Ban HJ; Oh IJ; Kim KS; Song SY; Na KJ; Ahn SJ; Choi S; Kim YC
Respirology; 2012 Jan; 17(1):127-33. PubMed ID: 21899657
[TBL] [Abstract][Full Text] [Related]
39. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
Sher DJ; Koshy M; Liptay MJ; Fidler MJ
Cancer; 2014 Jul; 120(13):2060-8. PubMed ID: 24692108
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of NQO1 C609T polymorphisms after postoperative radiation therapy in completely resected non-small cell lung cancer.
Song SY; Jeong SY; Park HJ; Park SI; Kim DK; Kim YH; Shin SS; Lee SW; Ahn SD; Kim JH; Lee JS; Choi EK
Lung Cancer; 2010 May; 68(2):278-82. PubMed ID: 19596483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
